dc.contributor.author | Feldman-Stewart, Deb | |
dc.contributor.author | Capirci, Carlo | |
dc.contributor.author | Brennenstuhl, Sarah | |
dc.contributor.author | Tong, Christine | |
dc.contributor.author | Abacioglu, Ufuk | |
dc.contributor.author | Gawkowska-Suwinska, Marzena | |
dc.contributor.author | Woerdehoff, Herbert | |
dc.date.accessioned | 2019-08-13T12:10:23Z | |
dc.date.accessioned | 2019-08-13T16:04:42Z | |
dc.date.available | 2019-08-13T12:10:23Z | |
dc.date.available | 2019-08-13T16:04:42Z | |
dc.date.issued | 2010 | |
dc.identifier.issn | 0167-8140 | |
dc.identifier.uri | https://dx.doi.org/10.1016/j.radonc.2009.12.038 | |
dc.identifier.uri | http://hdl.handle.net/11446/3357 | |
dc.description | WOS: 000276619500012 | en_US |
dc.description | PubMed ID: 20116122 | en_US |
dc.description.abstract | Background and purpose: Providing information to patients can improve their medical and psychological outcomes. We sought to identify core information needs common to most early-stage prostate cancer patients in participating countries. Material and methods: Convenience samples of patients treated 3-24 months earlier were surveyed in Canada, England, Italy, Germany, Poland, Portugal, Netherlands, Spain, and Turkey. Each participant rated the importance of addressing each of 92 questions in the diagnosis-to-treatment decision interval (essential/desired/no opinion/avoid). Multivariate modelling determined the extent of variance accounted by covariates, and produced an unbiased prediction of the proportion of essential responses for each question. Results: Six hundred and fifty-nine patients responded (response rates 45-77%). On average, 35-53 questions were essential within each country; similar questions were essential to most patients in most countries. Beyond cross-country similarities, each country showed wide variability in the number and which questions were essential. Multivariate modelling showed an adjusted R-squared with predictors country, age, education, and treatment group of only 6% of the variance. A core of 20 questions were predicted to be essential to >2/3 of patients. Conclusions: Core information can be identified across countries. However, providing the core should only be a first step; each country should then provide information tailored to the needs of the individual patient. (C) 2010 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 94 (2010) 328-333 | en_US |
dc.description.sponsorship | Kingston General Hospital Foundation; Prostate Cancer Charity UK | en_US |
dc.description.sponsorship | We would like to thank Weidong Kong for his time, effort and expertise in the General Linear Mixed Modelling. We would also like to thank all patients who took the time to participate in the survey. Finally, funding for the study was provided by the Kingston General Hospital Foundation, which supported data entry for the whole project, and by the Prostate Cancer Charity UK which supported patient recruitment in London, UK. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | ELSEVIER IRELAND LTD | en_US |
dc.identifier.doi | 10.1016/j.radonc.2009.12.038 | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Early-stage prostate cancer | en_US |
dc.subject | Patient information needs | en_US |
dc.subject | Patient education | en_US |
dc.title | Information needs of early-stage prostate cancer patients: A comparison of nine countries | en_US |
dc.type | article | en_US |
dc.relation.journal | RADIOTHERAPY AND ONCOLOGY | en_US |
dc.department | DBÜ | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.volume | 94 | en_US |
dc.identifier.startpage | 328 | en_US |
dc.identifier.endpage | 333 | en_US |
dc.contributor.authorID | 0000-0003-2904-5715 | en_US |
dc.contributor.authorID | 0000-0002-2481-5576 | en_US |
dc.contributor.authorID | 0000-0002-3950-8616 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.department-temp | [Feldman-Stewart, Deb] Queens Univ, Div Canc Care & Epidemiol, Canc Res Inst, Kingston, ON K7L 3N6, Canada -- [Abacioglu, Ufuk] Marmara Univ Hosp, Istanbul, Turkey -- [Capirci, Carlo] Aziends ULSS 18, Rovigo, Italy -- [Igdem, Sefik] Istanbul Bilim Univ, Istanbul, Turkey -- [van Gils, Francis -- Pijls-Johannesma, Madelon] Maastro Clin, Maastricht, Netherlands -- [Macias, Victor] Hosp Clin Univ Salamanca, Inst Oncol Valles Barcelona, Salamanca, Spain -- [Grillo, Isabel Monteiro -- Pimentel, Nuno] Univ Hosp Santa Maria, Lisbon, Portugal -- [Moynihan, Clare -- Parker, Chris] Inst Canc Res, London SW3 6JB, England -- [Moynihan, Clare -- Parker, Chris] Royal Marsden NHS Trust, London, England -- [Woerdehoff, Herbert] Klin Strahlentherapie, Magdeburg, Germany | en_US |